ONO Pharmaceutical Co's market cap is currently ¥731.71B. The company's EPS TTM is ¥157.402; its P/E ratio is 9.90; and it has a dividend yield of 5.16%. ONO Pharmaceutical Co is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is ¥22.98. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 502.67B	¥ 447.19B	¥ 361.36B	¥ 309.28B	¥ 292.42B
Gross Profit	¥ 375.55B	¥ 337.13B	¥ 267.85B	¥ 223.71B	¥ 213.36B
Operating Income	¥ 163.10B	¥ 141.96B	¥ 103.19B	¥ 98.33B	¥ 77.49B
EBITDA	¥ 181.98B	¥ 167.50B	¥ 128.54B	¥ 114.54B	¥ 94.00B
Net Income	¥ 127.98B	¥ 112.72B	¥ 80.52B	¥ 75.42B	¥ 59.70B
Balance Sheet
Cash & Short-Term Investments	¥ 166.14B	¥ 164.29B	¥ 116.97B	¥ 104.97B	¥ 100.42B
Total Assets	¥ 913.67B	¥ 882.44B	¥ 739.20B	¥ 746.84B	¥ 673.44B
Total Debt	¥ 8.86B	¥ 9.17B	¥ 8.80B	¥ 9.05B	¥ 8.36B
Net Debt	¥ -157.28B	¥ -86.97B	¥ -60.31B	¥ -51.99B	¥ -60.64B
Total Liabilities	¥ 115.06B	¥ 134.62B	¥ 77.53B	¥ 105.69B	¥ 105.42B
Stockholders' Equity	¥ 792.96B	¥ 741.87B	¥ 655.91B	¥ 635.55B	¥ 562.48B
Cash Flow
Free Cash Flow	¥ 89.83B	¥ 145.11B	¥ 49.55B	¥ 53.68B	¥ 51.71B
Operating Cash Flow	¥ 110.66B	¥ 159.61B	¥ 61.83B	¥ 73.98B	¥ 74.16B
Investing Cash Flow	¥ 48.08B	¥ -100.26B	¥ 6.04B	¥ -57.59B	¥ -10.23B
Financing Cash Flow	¥ -89.85B	¥ -32.48B	¥ -60.24B	¥ -24.75B	¥ -54.72B

Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History

Income Statement >

ONO Pharmaceutical Co Debt to Assets

Balance Sheet >

ONO Pharmaceutical Co Cash Flow

Cash Flow >

ONO Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing